1338 Crystallography-guided characterization of novel cytosolic DNase 3’ repair exonuclease 1 (TREX1) inhibitors

• Dara Burdette,
• Thomas Dubensky,
• Nathan Standifer,
• Henry Johnson,
• Alyssa Mullenix,
• Anja Holtz,
• Dave Freund,
• Valerie Chen,
• David Hsieh,
• Jesus Garcia Lopez,
• Jamie Cope,
• Peppi Prasit,
• Anne Moon

Affiliations

Dara Burdette

1Tempest Therapeutics, San Francisco, CA, USA

Thomas Dubensky

Aff1 grid.417411.6Aduro BioTech Berkeley CA USA

Nathan Standifer

Astrazeneca, Gaithersburg, MD, USA

Henry Johnson

Kezar Life Sciences

Alyssa Mullenix

Senti Biosciences, Inc., South San Francisco, CA, USA

Anja Holtz

1Tempest Therapeutics, Berkeley, CA, USA

Dave Freund

1Tempest Therapeutics, Berkeley, CA, USA

Valerie Chen

1Tempest Therapeutics, San Francisco, CA, USA

David Hsieh

1Tempest Therapeutics, San Francisco, CA, USA

Jesus Garcia Lopez

1Tempest Therapeutics, San Francisco, CA, USA

Jamie Cope

1Tempest Therapeutics, San Francisco, CA, USA

Peppi Prasit

1Tempest Therapeutics, San Francisco, CA, USA

Anne Moon

1Tempest Therapeutics, San Francisco, CA, USA